| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
188,370,000 |
| Market
Cap: |
16.70(B) |
| Last
Volume: |
1,778,607 |
Avg
Vol: |
1,398,026 |
| 52
Week Range: |
$76.22 - $99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 811 |
| Guru Rank Value : 0.9 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
3,625 |
| Total Buy Value |
$0 |
$0 |
$0 |
$314,469 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
159,588 |
251,929 |
319,053 |
656,089 |
| Total Sell Value |
$13,270,852 |
$21,508,551 |
$27,661,182 |
$61,420,002 |
| Total People Sold |
5 |
6 |
7 |
7 |
| Total Sell Transactions |
10 |
19 |
27 |
56 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Swiedler Stuart J |
Senior VP , ClinicalOfficer |
• – – |
2004-12-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
| Baffi Robert |
SVP, Technical Operations |
• – – |
2004-10-31 |
4 |
A |
$3.51 |
$12,504 |
D/D |
3,562 |
18,493 |
|
- |
|
| Landau Jeffrey |
SVP, Administration |
• – – |
2004-10-31 |
4 |
A |
$3.51 |
$2,499 |
D/D |
712 |
2,740 |
|
- |
|
| Kakkis Emil D |
SVP, Business Operations |
• – – |
2004-10-31 |
4 |
A |
$3.51 |
$6,754 |
D/D |
1,924 |
25,034 |
|
- |
|
| Drapeau Louis |
Chief Executive Officer |
• – – |
2004-10-31 |
4 |
A |
$3.51 |
$12,943 |
D/D |
3,687 |
10,930 |
|
- |
|
| Urquhart John |
Director |
– • – |
2004-08-11 |
5 |
S |
$4.77 |
$4,770 |
D/D |
(1,000) |
0 |
|
- |
|
| Starr Christopher M |
SVP, Chief Scientific Officer |
• – – |
2004-06-03 |
4 |
AS |
$7.61 |
$76,375 |
D/D |
(10,000) |
305,176 |
|
- |
|
| Baffi Robert |
SVP, Technical Operations |
• – – |
2004-05-10 |
4 |
B |
$6.12 |
$48,960 |
D/D |
8,000 |
14,931 |
2.74 |
- |
|
| Kakkis Emil D |
SVP, Business Operations |
• – – |
2004-05-06 |
4 |
B |
$6.48 |
$97,400 |
I/I |
15,000 |
26,110 |
1.99 |
- |
|
| Price Fredric D |
Chief Executive Officer |
• • – |
2004-05-06 |
4 |
B |
$6.27 |
$94,850 |
D/D |
15,000 |
79,285 |
2.81 |
- |
|
| Drapeau Louis |
CFO, VP, Finance & Secretary |
• – – |
2004-05-03 |
4 |
A |
$5.70 |
$12,502 |
D/D |
2,192 |
7,243 |
|
- |
|
| Landau Jeffrey |
SVP, Administration |
• – – |
2004-05-03 |
4 |
A |
$5.10 |
$2,504 |
D/D |
491 |
2,028 |
|
- |
|
| Baffi Robert |
SVP, Technical Operations |
• – – |
2004-05-03 |
4 |
A |
$5.10 |
$12,357 |
D/D |
2,423 |
6,931 |
|
- |
|
1213 Records found
|
|
Page 49 of 49 |
|
|
1.44 (1.6%) 
